0001209191-13-048099.txt : 20131011
0001209191-13-048099.hdr.sgml : 20131011
20131011093800
ACCESSION NUMBER: 0001209191-13-048099
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130912
FILED AS OF DATE: 20131011
DATE AS OF CHANGE: 20131011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000707511
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521253406
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 BETHESDA METRO CENTER
STREET 2: SUITE 700
CITY: BETHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: 3019611992
MAIL ADDRESS:
STREET 1: 3 BETHESDA METRO CENTER
STREET 2: SUITE 700
CITY: BETHESDA
STATE: MD
ZIP: 20814
FORMER COMPANY:
FORMER CONFORMED NAME: ALPHA 1 BIOMEDICALS INC
DATE OF NAME CHANGE: 19950719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bowles L Thompson
CENTRAL INDEX KEY: 0001355785
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15070
FILM NUMBER: 131147061
MAIL ADDRESS:
STREET 1: C/O REGENERX BIOPHARMACEUTICALS, INC.
STREET 2: 3 BETHESDA METRO CENTER ? SUITE 630
CITY: BETHESDA
STATE: MD
ZIP: 20814
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-09-12
0
0000707511
REGENERX BIOPHARMACEUTICALS INC
RGRX
0001355785
Bowles L Thompson
C/O REGENERX BIOPHARMACEUTICALS, INC.
15245 SHADY GROVE ROAD, SUITE 470
ROCKVILLE
MD
20850
1
0
0
0
Convertible Promissory Note (right to buy)
0.06
2013-09-12
4
A
0
5000.00
5000.00
A
2013-09-12
2018-09-10
Common Stock
83333
5000.00
D
Represents the principal amount of the Convertible Promissory Note issued by the issuer to the reporting person on September 12, 2013.
Represents the shares of common stock issuable upon conversion of the principal amount of the Convertible Promissory Note.
/s/ J.J. Finkelstein, Attorney-in-Fact
2013-10-11